Abstract:Designing dual‐drug‐loaded polymeric nanoparticles for combination therapy presents significant challenges, particularly in achieving precise drug encapsulation and stability. This study utilizes computational methodologies to guide the formulation process, employing machine learning to optimize nanoprecipitation conditions. By screening 176 formulations, critical factors affecting successful co‐encapsulation are identified, demonstrating a practical method to address the complexities of dual‐drug delivery systems. Single‐drug therapies or monotherapies are often inadequate, particularly in the case of life‐threatening diseases like cancer. Consequently, combination therapies emerge as an attractive strategy. Cancer nanomedicines have many benefits in addressing the challenges faced by small molecule therapeutic drugs, such as low water solubility and bioavailability, high toxicity, etc. However, it remains a significant challenge in encapsulating two drugs in a nanoparticle. To address this issue, computational methodologies are employed to guide the rational design and synthesis of dual‐drug‐loaded polymer nanoparticles while achieving precise control over drug loading. Based on the sequential nanoprecipitation technology, five factors are identified that affect the formulation of drug candidates into dual‐drug loaded nanoparticles, and then screened 176 formulations under different experimental conditions. Based on these experimental data, machine learning methods are applied to pin down the key factors. The implementation of this methodology holds the potential to significantly mitigate the complexities associated with the synthesis of dual‐drug loaded nanoparticles, and the co‐assembly of these compounds into nanoparticulate systems demonstrates a promising avenue for combination therapy. This approach provides a new strategy for enabling the streamlined, high‐throughput screening and synthesis of new nanoscale drug‐loaded entities.

Phase Separation‐induced Nanoprecipitation for Making Polymer Nanoparticles with High Drug Loading

Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential Nanoprecipitation

Phase Separation and Crystallization of Binary Nanoparticles Induced by Polymer Brushes

Development of a concentration‐controlled sequential nanoprecipitation for making lipid nanoparticles with high drug loading

Continuous Processing of Phase-Change Materials into Uniform Nanoparticles for Near-Infrared-triggered Drug Release

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Electrospun Polymer Blend Nanofibers for Tunable Drug Delivery: The Role of Transformative Phase Separation on Controlling the Release Rate

Controlled Fabrication of Drug‐loaded Protein Nanoparticles via Flash Nanoprecipitation

Controllable Loading and Release of Nanodrugs in Polymeric Vesicles

Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor

Morphology control of trimer particles via one-step co-precipitation and controlled phase separation

Protein-nanoparticle co-assembly supraparticles for drug delivery: Ultrahigh drug loading and colloidal stability, and instant and complete lysosomal drug release

Aqueous nanoprecipitation for programmable fabrication of versatile biopolymer nanoparticles

Hydrogen Bonding Enhanced Drug-Polymer Interaction for Efficient Drug Loading and Delivery

Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers.

Microfluidic Manufacturing of SN-38-Loaded Polymer Nanoparticles with Shear Processing Control of Drug Delivery Properties

Diverse Particle Carriers Prepared by Co‐Precipitation and Phase Separation: Formation and Applications

Microphase Separation in Neutral Homopolymer Blends Induced by Salt-Doping

Translatable High Drug-Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers.

Computationally guided design and synthesis of dual‐drug loaded polymeric nanoparticles for combination therapy

Nanoparticle Formulation Composition Analysis by Liquid Chromatography on Reversed-Phase Monolithic Silica